Werewolf Therapeutics マネジメント
マネジメント 基準チェック /34
Werewolf Therapeuticsの CEO はDan Hicklinで、 Oct2017年に任命され、 の在任期間は 7.08年です。 の年間総報酬は$ 1.37Mで、 42.7%給与と57.3%のボーナス（会社の株式とオプションを含む）で構成されています。 は、会社の株式の1.45%を直接所有しており、その価値は$ 1.23M 。経営陣と取締役会の平均在任期間はそれぞれ3.9年と5.1年です。
主要情報
Dan Hicklin
最高経営責任者
US$1.4m
報酬総額
| CEO給与比率 | 42.7% |
| CEO在任期間 | 7.1yrs |
| CEOの所有権 | 1.5% |
| 経営陣の平均在職期間 | 3.9yrs |
| 取締役会の平均在任期間 | 5.1yrs |
経営陣の近況
Recent updates
Werewolf Therapeutics (NASDAQ:HOWL) Has Debt But No Earnings; Should You Worry?
Nov 14
Is Werewolf Therapeutics (NASDAQ:HOWL) Using Debt Sensibly?
Jul 31Werewolf Therapeutics: Continuing To Advance And Show More Promise In Phase 1
Jul 01Some Werewolf Therapeutics, Inc. (NASDAQ:HOWL) Shareholders Look For Exit As Shares Take 34% Pounding
Jun 04Werewolf Therapeutics: In The Hunt For Success In The Cytokine Space
Apr 04Werewolf Therapeutics, Inc.'s (NASDAQ:HOWL) Share Price Boosted 27% But Its Business Prospects Need A Lift Too
Feb 07Is Werewolf Therapeutics (NASDAQ:HOWL) A Risky Investment?
Jan 19There's No Escaping Werewolf Therapeutics, Inc.'s (NASDAQ:HOWL) Muted Revenues Despite A 28% Share Price Rise
Dec 09Analysts Just Shipped A Captivating Upgrade To Their Werewolf Therapeutics, Inc. (NASDAQ:HOWL) Estimates
Sep 30Werewolf Therapeutics, Inc. (NASDAQ:HOWL) Second-Quarter Results: Here's What Analysts Are Forecasting For This Year
Aug 13We're Hopeful That Werewolf Therapeutics (NASDAQ:HOWL) Will Use Its Cash Wisely
May 06Werewolf Therapeutics (NASDAQ:HOWL) Is In A Good Position To Deliver On Growth Plans
Jan 27We're Not Very Worried About Werewolf Therapeutics' (NASDAQ:HOWL) Cash Burn Rate
Oct 24We're Hopeful That Werewolf Therapeutics (NASDAQ:HOWL) Will Use Its Cash Wisely
Jul 08Werewolf Therapeutics (NASDAQ:HOWL) Is In A Good Position To Deliver On Growth Plans
Mar 24Werewolf Therapeutics (NASDAQ:HOWL) Is In A Good Position To Deliver On Growth Plans
Dec 09CEO報酬分析
| 日付 | 総報酬 | 給与 | 会社業績 |
|---|---|---|---|
| Sep 30 2024 | n/a | n/a | -US$62m |
| Jun 30 2024 | n/a | n/a | -US$54m |
| Mar 31 2024 | n/a | n/a | -US$42m |
| Dec 31 2023 | US$1m | US$583k | -US$37m |
| Sep 30 2023 | n/a | n/a | -US$37m |
| Jun 30 2023 | n/a | n/a | -US$41m |
| Mar 31 2023 | n/a | n/a | -US$50m |
| Dec 31 2022 | US$2m | US$530k | -US$54m |
| Sep 30 2022 | n/a | n/a | -US$60m |
| Jun 30 2022 | n/a | n/a | -US$62m |
| Mar 31 2022 | n/a | n/a | -US$115m |
| Dec 31 2021 | US$2m | US$498k | -US$202m |
| Sep 30 2021 | n/a | n/a | -US$205m |
| Jun 30 2021 | n/a | n/a | -US$197m |
| Mar 31 2021 | n/a | n/a | -US$127m |
| Dec 31 2020 | US$3m | US$425k | -US$28m |
報酬と市場: Danの 総報酬 ($USD 1.37M ) は、 US市場 ($USD 649.07K ) の同規模の企業の平均を上回っています。
報酬と収益: Danの報酬は、過去 1 年間の会社の業績と一致しています。
CEO（最高経営責任者
Dan Hicklin (60 yo)
7.1yrs
在職期間
US$1,366,904
報酬
Dr. Daniel J. Hicklin, Ph D., also known as Dan, Founded Werewolf Therapeutics, Inc. in October 2017 and has been its President and Chief Executive Officer since August 2019. He serves on its Board of Dire...
リーダーシップ・チーム
| 名称 | ポジション | 在職期間 | 報酬 | 所有権 |
|---|---|---|---|---|
| Founder | 7.1yrs | US$1.37m | 1.45% $ 1.2m | |
| CFO, Treasurer & Assistant Secretary | 3.8yrs | US$815.59k | 0% $ 0 | |
| Chief Medical Officer | 4yrs | US$855.77k | 0% $ 0 | |
| Senior Vice President of Research | less than a year | データなし | データなし | |
| Chief Technology Officer | 3.4yrs | US$3.86m | データなし | |
| Chief Business Officer | 4.3yrs | データなし | データなし |
3.9yrs
平均在職期間
64yo
平均年齢
経験豊富な経営陣: HOWLの経営陣は 経験豊富 であると考えられます ( 3.9年の平均在職年数)。
取締役
| 名称 | ポジション | 在職期間 | 報酬 | 所有権 |
|---|---|---|---|---|
| Founder | 7.1yrs | US$1.37m | 1.45% $ 1.2m | |
| Independent Chairman of the Board | 7.1yrs | US$104.03k | 0% $ 0 | |
| Independent Director | 3.5yrs | US$78.66k | 0% $ 0 | |
| Member of Scientific Advisory Board | no data | データなし | データなし | |
| Member of Scientific Advisory Board | no data | データなし | データなし | |
| Independent Director | 5yrs | US$62.32k | 0.035% $ 29.5k | |
| Member of Scientific Advisory Board | no data | データなし | データなし | |
| Member of Scientific Advisory Board & Director | 6.3yrs | データなし | 0.032% $ 27.4k | |
| Independent Director | 5.3yrs | US$78.53k | 4.59% $ 3.9m | |
| Independent Director | 3.1yrs | US$65.36k | 0% $ 0 | |
| Independent Director | 3.9yrs | US$72.53k | 0% $ 0 | |
| Member of Scientific Advisory Board | no data | データなし | データなし |
5.1yrs
平均在職期間
61yo
平均年齢
経験豊富なボード: HOWLの 取締役会 は 経験豊富 であると考えられます ( 5.1年の平均在任期間)。